Basics of EKG Interpretation with an Oncology Focus
Tracy Vernon-Platt, DNP, ANP-BC, will present on Basics of EKG Interpretation with an Oncology Focus
Category
  • Advanced Practice Provider
Format
  • Live Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Event date October 16, 2024
CPP Panel: Targeted Therapy Toxicities and Management
Kevin Chen, PharmD, MS; Aimee Faso, PharmD, BCOP, CPP; Bianka Patel, PharmD, BCOP, CPP, will discuss "CPP Panel: Targeted Therapy Toxicities and Management" in this months APP webinar series.
Category
  • Advanced Practice Provider
Format
  • Live Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Event date July 17, 2024
Assessing Anemia and Thrombocytopenia, and When to Be Concerned
Nancy Vogler, RN, MSN, AGPCNP, will present on "Assessing Anemia and Thrombocytopenia, and When to Be Concerned."
Category
  • Advanced Practice Provider
Format
  • Live Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Event date June 19, 2024
Using Acceptance and Commitment Therapy to Help Cancer Survivors Move Forward After Treatment
Melissa Holt, DNP, PMHNP-BC, and Lisa Stewart Kanser, PsyD will present on the topic of "Using Acceptance and Commitment Therapy to Help Cancer Survivors Move Forward After Treatment".
Category
  • Advanced Practice Provider
Format
  • Live Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Event date May 15, 2024
Let’s Take a BiTE Out of CRS and Neurotoxicity
Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Peritoneal Carcinomatosis: The Good, the Bad, and the Ugly
Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities
Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Lung Cancer Screening Essentials
This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Oncologic Emergencies: Superior Vena Cava Syndrome, Hypercalcemia, and SIADH
Allison Phillips, MPAP, MHPE, PA-C, reviews the clinical manifestations, underlying causes, and management of some of the most common emergencies facing patients undergoing cancer treatment, including Superior Vena Cava Syndrome, Hypercalcemia, and SIADH.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Integrating Germline Pharmacogenomic Testing into Oncology Care
Patients undergoing treatment for cancer utilize many medications that have relevant drug-gene interactions. The use of pharmacogenomic testing can assist with drug selection, drug dosing, and the development of personalized medication monitoring plans. Amber Cipriani, PharmD, BCOP, will describe some common examples of drug-gene interactions relevant to oncology. She will also discuss current efforts to expand the use of pharmacogenomic testing into current clinical practice.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation

Pages